|Day Low/High||52.20 / 53.45|
|52 Wk Low/High||43.62 / 57.05|
If anyone can sell it to antitrust regulators, T-Mobile CEO John Legere can.
Better-than-expected earnings will help soothe market jitters in the second quarter.
Charts suggest there may be hope for Walgreens bulls.
The keys? Preparation, Discipline and Plan of Action.
Volume and other indicators suggest more weakness ahead.
The 'dash 1000' is the largest Airbus A350 the company has every produced.
As Albertsons prepares to bring a significant piece of Rite Aid into its family, we took a look back at how the grocer became the mega chain it is today.
Welcome back from the long weekend, Wall Street. Here's what you must know.
The Wall Street Journal reported that Walgreens Boots Alliance has contacted AmerisourceBergen about a possible takeover.
With Dow futures pointed south, it looks to be another interesting day on Wall Street. Here's what you need to know.
The rally from the late October low has been stronger than other rallies and suggests that the rally in WBA is not over just yet.
We see a notable shift away from traditional large-cap pharmaceutical stocks to more specialized niches.
A move to catch up with fundamentals is likely in the future.
CVS stock looks like it is making a turnaround. WBA is a different story.
With WBA trading lower this wintry day a fresh look at the charts is in order.
On Monday, more natural gas was burnt in a nationwide effort to stay warm than ever before.
With CVS-Aetna in the news, a fresh look at WBA seems in order.
Netflix' power means that the stock is likely to go higher, not lower.
But many businesses have good reason to fear it.
Amazon, Microsoft and Alphabet all reached all-time highs Friday.
Amid reports that CVS Health is in discussions to purchase health insurance giant Aetna for $66 billion, TheStreet's founder and Action Alerts PLUS Portfolio Manager Jim Cramer thinks regulators would approve such a deal.
An observation: Despite being within 1% of the all-time high in the S&P Index, this week's feature was a number of investment potholes --relatively large sized individual fundamental disappointments followed by marked stock price drops. Celgene , B...